Skip to main content
Elaine Brennan wearing a black shirt and pink jacket
Vice President, International
Northwell Holdings and Ventures

Elaine Brennan is one of the leaders of True North, a Northwell Health entity established to develop and invest in innovative products, technologies and services that will generate revenue to support the health system’s mission of delivering quality care, innovative research and education.

Ms. Brennan joined Northwell to create Pharma Ventures, a group tasked with establishing an innovative approach to managing and developing more collaborative and strategic relationships with the pharmaceutical industry.

Previously, Ms. Brennan was the CEO of Socrates, a health care information technology company, where she led the development and launch of its electronic health records system in the US. She also worked with Enterprise Ireland, managing the Irish life sciences companies entering the US market and she founded Gastroenterology Ireland, which combined a cluster of companies, research and development, and Irish opinion leaders in Ireland and the US.

Her pharmaceutical career at Roche, Bristol Myers Squibb and AbbVie included marketing/sales and clinical roles launching blockbuster products in the virology sector.

Ms. Brennan has published scientific articles on genetic engineering and biodegradable polymers applications, and patented many products in the same area. She earned her science degree in the United Kingdom and her early education in County Galway and Belgium.

The latest news for Elaine Brennan
View more articlesView more articles
In Irish Independent, Elaine Brennan details the health system's collaboration with Irish-based companies.
True North Enterprises is providing retail and investment opportunities, greater connections with pharmaceutical/biotech companies and discounts through collective buying power for Northwell.
Northwell's Pharma Ventures builds new business and partnerships with pharmaceutical companies.